Response to Yang et. al

J Mol Med (Berl). 2019 May;97(5):739-740. doi: 10.1007/s00109-019-01775-z. Epub 2019 Mar 23.

Authors

Yoshimi Asano¹, Chiemi Saigo², Yusuke Kito², Yoshinori Iwata¹, Kazuhiro Yoshida¹, Tamotsu Takeuchi³

Affiliations

¹ Department of Surgical Oncology, Gifu University Graduate School of Medicine , Gifu, Japan.
² Department of Pathology and Translational Research, Gifu University Graduate School of Medicine, Gifu, 501-1194, Japan.
³ Department of Pathology and Translational Research, Gifu University Graduate School of Medicine, Gifu, 501-1194, Japan. takeutit08@gmail.com.

PMID: 30903230
DOI: 10.1007/s00109-019-01775-z

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinogenesis*
Cell Nucleus
Cell Transformation, Neoplastic*
Humans
Receptors, LDL

Substances

Receptors, LDL